INO

INOVIO PHARMACEUTICALS INC

INO·45773H409·US·Common Stock·Healthcare - Biotechnology-13D/G

INO (INOVIO PHARMACEUTICALS INC) is held by 49 institutional investors as of Q2 2026. Largest holders: FMR LLC ($9.3M), VANGUARD CAPITAL MANAGEMENT LLC ($4M), D. E. Shaw & Co., Inc. ($1.5M). Net institutional sentiment: Mixed.

49
Holders
(3 Elite)
$22.7M
Total Value
58% (53)
Consensus
31 buying - 22 selling
13F: Insider & Congress: Updated regularly
INO

Smart Money Verdict

View all
Loading verdict
Held by 49 funds
3 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders none · Activists Aug 12, 2026 · Congress none

ActivistADAdage Capital Management, L.P.4.0%Aug 12, 2026
ActivistRA Capital Management, L.P.RA Capital Management, L.P.9.9%Aug 7, 2026
ActivistFMR LLCFMR LLC10.3%Aug 6, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
8.5M(-9.5%)$9.3M0.0%-26.14%
0
Increased
3.7M(+25.8%)$4M0.0%-16.71%
33
Decreased
1.4M(-38.9%)$1.5M0.0%-35.19%
0
Increased
1.2M(+217.6%)$1.4M0.0%-8.54%
41
Increased
802,751(+0.2%)$883,7490.0%-91.58%
17
Decreased
796,107(-43.6%)$875,7180.0%-45.34%
0
Increased
779,057(+17.6%)$856,9630.0%-21.86%
20
Increased
480,769(+22.6%)$528,8460.0%-17.36%
29
New
478,950$526,8450.0%+18.18%
33
Decreased
361,339(-43.9%)$397,4730.0%-51.55%
0
Increased
336,610(+13.6%)$370,2710.0%-65.83%
18
Increased
262,320(+5.1%)$288,5520.0%-36.12%
17
New
258,928$284,8210.0%+18.18%
32
Decreased
241,775(-15.6%)$265,9520.0%-22.62%
0
Decreased
174,394(-41.6%)$191,8330.0%-89.32%
0
New
150,000$165,0000.0%+18.18%
31
New
133,648$147,0120.0%+18.18%
31
Increased
124,525(+305.7%)$136,9770.0%-7.54%
24
Decreased
105,833(-50.2%)$116,4160.0%-41.49%
0
Increased
93,720(+109.5%)$103,0920.0%-7.82%
24

Showing 1-20 of 58

1 / 3
INOINOINOVIO PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used